Francesca Sperandi

Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer

Andrea Martoni, Antonella Marino, Francesca Sperandi et al. · European Journal of Cancer · 2004 · 73 citations

Medicine, Oncology, Pharmacology +9

PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Filippo Gustavo Dall’Olio, Francesco Gelsomino, Nicole Conci et al. · Clinical Lung Cancer · 2021 · 71 citations

Medicine, Immunology, Oncology +17

The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab

Francesca Di Fabio, Carmine Pinto, Fabiola Lorena Rojas Llimpe et al. · Gastric Cancer · 2007 · 54 citations · Full text

Medicine, Oncology, Chemotherapy +13

Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma

Emi Dika, Annalisa Patrizi, Simone Ribero et al. · European Journal of Dermatology · 2016 · 46 citations

Medicine, Dermatology, Oncology +13

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

Diego Cortinovis, Rita Chiari, Annamaria Catino et al. · Anticancer Research · 2019 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17